Syphilis and Bacterial Sexually Transmitted Infections

Rook's Textbook of Dermatology: Eighth Edition

Volumn 2, Issue , 2010, Pages 1536-1572

  Kinghorn, George R ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Chancroid; Gonorrhoea; Granuloma inguinale (donovanosis); HIV AIDS; Lymphogranuloma venereum; Sexually transmitted infections; Syphilis

Indexed keywords

EID: 84888669700     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444317633.ch34     Document Type: Chapter

References (191)

1. Morton RS. Sexual Freedom and Venereal Disease. London: Peter Owen, 1971.
2. Guthe T. The treponematoses as a world problem. Br J Vener Dis 1960; 36: 67-77.
3. Idsøe O, Guthe T. The rise and fall of the treponematoses. Br J Vener Dis 1967; 43: 227-43.
4. Knudson EA. A clinical study on 29 cases of debatable STS and TPI seroreactions in Greenland. Acta Derm Venereol (Stockh) 1974; 54: 311-6.
5. Ministry of Health Report for England and Wales. Venereal diseases in England and Wales. Br J Vener Dis 1966; 42: 50-7.
6. Schamberg IL. Syphilis and sisyphus. Br J Vener Dis 1963; 39: 87-97.
7. Jacobs DS. Syphilis in Australian Aborigines in the Northern Territory. Med J Aust 1978; 1: 10-2.
8. Aiken CJ. The causes of perinatal mortality in Bulawayo, Zimbabwe. Cent Afr J Med 1992; 38: 263-81.
9. Schmid GP, Stoner BP, Hawkes S, Broutet N. The need and plan for global elimination of congenital syphilis. Sex Transm Dis 2007; 34 (Suppl. 7): S5-10.
10. WHO. Treponemal Infections. Technical Report Series No. 674. Geneva: World Health Organization, 1982.
11. Thirumoorthy T, Lee CT, Lim KB. Epidemiology of infectious syphilis in Singapore. Genitourin Med 1986; 62: 75-7.
12. Lingolf T. Rapid increase of syphilis and gonorrhea in parts of the former USSR. Sex Transm Dis 1995; 22: 160-1.
13. Rubins A, Rubins S, Jakabsone I. Syphilis and gonorrhea in the Baltic countries. Sex Transm Infect 2000; 76: 214.
14. Bernstein KT, Tulloch R, Montes J et al. Outbreak of syphilis among men who have sex with men-Southern California, 2000. MMWR Morb Mortal Wkly Rep 2001; 50: 117-20.
15. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2004 Supplement, Syphilis Surveillance Report. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, December 2005.
16. Doherty L, Fenton K, O'Flanagan D, Courtier E. Evidence for Increased Transmission of Syphilis Among Homosexual Men and Heterosexual Men and Women in Europ. Eurosurveillance Weekly, 2000. www.eurosurv.org/2000/001214.htm 17 Heffelfinger JD, Swint EB, Berman SM, Weinstock HS. Trends in primary and secondary syphilis among men who have sex with men in the United States. Am J Public Health 2007; 97: 1076-83.
17. Simms I, Fenton K, Ashton M et al. The re-emergence of syphilis in the United Kingdom: the new epidemic phases. Sex Transm Dis 2005; 32: 220-6.
18. Dougan S, Evans BG, Elford J. Sexually transmitted infections in Western Europe among HIV-positive men who have sex with men. Sex Transm Dis 2007; 34: 783-90.
19. Edwards EA. Detecting Treponema pallidum in primary lesions by the fluorescent antibody technique. Public Health Rep 1962; 77: 427-43.
20. Jue R, Puffer J, Wood RM et al. Comparison of the fluorescent and conventional darkfield methods for the detection of Treponema pallidum in syphilitic lesions. Am J Clin Pathol 1967; 47: 809-11.
21. Kellogg OS, Deacon WE. A new rapid immunof uorescent staining technique for identification of Treponema pallidum and Neisseria gonorrhoeae. Proc Soc Exp Biol Med 1964; 115: 963-5.
22. Norris SJ, Cox DL, Weinstock GM. Biology of Treponema pallidum: correlation of functional activities with genome sequence data. J Mol Microbiol Biotechnol 2001; 3: 37-62.
23. Van Voorhis WC, Barrett LK, Koelle DM et al. Primary and secondary syphilis lesions contain mRNA for Th1 cytokines. J Infect Dis 1996; 173: 491-5.
24. Riley BS, Oppenheimer-Marks N, Radolf JD, Norgard MV. Virulent Treponema pallidum promotes adhesion of leukocytes to human vascular endothelial cells. Infect Immun 1994; 62: 4622-5.
25. Fitzgerald TJ. The Th1/Th2-like switch in syphilitic infection: is it detrimental? Infect Immun 1992; 60: 3475-9.
26. Pope V, Larsen SA, Rice RJ et al. Flow cytometric analysis of peripheral blood lymphocyte immunophenotypes in persons infected with Treponema pallidum. Clin Diagn Lab Immunol 1994; 1: 121-4.
27. LaFond RE, Molini BJ, Van Voorhis WC, Lukehart SA. Antigenic variation of TprK V regions abrogates specific antibody binding in syphilis. Infect Immun 2006; 74: 6244-51.
28. Radolf JD. Treponema pallidum and the quest for outer membrane proteins. Mol Microbiol 1995; 16: 1067-73.
29. Gjestland T. The Oslo study of untreated syphilis. Acta Derm Venereol (Stockh) 1955; 35 (Suppl. 34): 3-368.
30. Talbot MD, Morton RS. The Tuskegee study of untreated syphilis. Eur J STD 1984; 1: 125-32.
31. Yobs AR, Brown L, Hunter EF. Fluorescent antibody technique in early syphilis. Arch Pathol 1964; 77: 220-9.
32. Edwards S, Carne C. Oral sex and the transmission of non-viral STIs. Sex Transm Infect 1998; 74: 95-100.
33. Dunlop EMC. Some aspects of infectious syphilis today. Public Health 1964; 78: 259-67.
34. Kinghorn GR, Hafiz S, McEntergart MG. Pathogenic microbiological flora of genital ulcers in Sheffield with particular reference to herpes simplex virus and Haemophilus ducreyi. Br J Vener Dis 1982; 58: 377-80.
35. Evans AJ, Summerly R. Pseudo-chancre redux with negative serology. Br J Vener Dis 1964; 40: 222-4.
36. Lannigan-O'Keefe FM. Pseudo-chancre redux. BMJ 1964; ii: 212.
37. Gallup DG, Cowherd DW. Syphilitic cervicitis. A report on a case. Obstet Gynecol 1978; 52 (Suppl. 1): 125-45.
38. Don PC, Rubinstein R, Christie S. Malignant syphilis (lues maligna) and concurrent infection with HIV. Int J Dermatol 1995; 34: 403-7.
39. Van der Ploeg DE, Stagnone JJ. Eyebrow alopecia in secondary syphilis. Arch Dermatol 1982; 90: 172-3.
40. Van der Willigen AH, Peereboom-Wynia JDR. Hair studies in patients with primary and secondary syphilis. Acta Derm Venereol (Stockh) 1987; 67: 250-4.
41. Margo CE, Hamed LM. Ocular syphilis. Surv Ophthalmol 1992; 37: 203-5.
42. Masterton G. Oro-genital aphthosis. Br J Vener Dis 1965; 41: 282-96.
43. Laird SM. Yaws in Manchester. Br J Vener Dis 1955; 31: 30-2.
44. Wray PM. Bejel in Sheffield. Br J Vener Dis 1966; 42: 25-7.
45. Johnson RA, White M. Syphilis in the 1990s: cutaneous and neurologic manifestations. Semin Neurol 1992; 12: 287-98.
46. Scheck DN, Hook EW III. Neurosyphilis. Infect Dis Clin North Am 1994; 8: 769-85.
47. Morrison AW. On syphilis and the ear-an otologist's view. Genitourin Med 1992; 68: 420-2.
48. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3-17.
49. Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clin Infect Dis 2007; 44: 1222-8.
50. Yinnon AM, Coury-Doniger P, Polito R, Richman RC. Serologic response to treatment of syphilis in patients with HIV infection. Arch Intern Med 1996; 156: 321-5.
51. Hutchinson CM, Hook EW III, Shepherd M et al. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 1994; 121: 94-100.
52. Brightbill TC, Ihmeidan IH, Post MJ et al. Neurosyphilis in HIV-positive and HIV-negative patients: neuroimaging findings. Am J Neuroradiol 1995; 16: 703-11.
53. Malone JL, Wallace MR, Hendrick BB et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med 1995; 99: 55-63.
54. Stray-Pederson B. Economic evaluation of maternal screening to prevent congenital syphilis. Sex Transm Dis 1983; 10: 167-72.
55. Clay J. Ante-natal screening for syphilis (Editorial). BMJ 1989: 299: 409-10.
56. Nicoll A, Moisley C. Ante-natal screening for syphilis (Editorial). BMJ 1994; 308: 1253-4.
57. Simms I, Ward H. Congenital syphilis in the United Kingdom. Sex Transm Infect 2006; 82: 1.
58. Harter CA, Benirschke K. Fetal syphilis in the fist trimester. Am J Obstet Gynecol 1976; 124: 705-11.
59. Moore JE. Recent advances in the study of venereal diseases. Br J Vener Dis 1949; 45: 169-78.
60. Laird SM. Elimination of congenital syphilis. Br J Vener Dis 1959; 35: 15-9.
61. PHLS, DHSS & PS and the Scottish ISD(D5) Collaborative Group. Sexually Transmitted Infections in the UK: New Episodes Seen at Genitourinary Medicine Clinics. 1995 to 2000. London: Public Health Laboratory Service, 2001.
62. Welch J. Antenatal screening for syphilis (Editorial). BMJ 1998; 317: 1605-6.
63. Desenclos JC, Scaggs M, Wroen JE. Characteristics of mothers of live infants with congenital syphilis in Florida, 1987-89. Am J Epidemiol 1992; 136: 657-61.
64. McFarlin BL, Bottoms SF, Dock BS, Isada NB. Epidemic syphilis: maternal factors associated with congenital infection. Am J Obstet Gynecol 1994; 170: 535-40.
65. Thompson BL, Matuszak D, Dwyer DM et al. Congenital syphilis in Maryland 1989-91: the effect of changing the definition and opportunities for prevention. Sex Transm Dis 1995; 22: 364-9.
66. Centers for Disease Control and Prevention. STD Surveillance 2005 National Profile. http://www.cdc.gov/STD/stats/syphilis.htm
67. Schwartz DA, Larsen SA, Beck-Sangue C et al. Pathology of the umbilical cord in congenital syphilis: analysis of 25 specimens using histochemistry and immunofluorescent antibody to Treponema pallidum. Hum Pathol 1995; 26: 784-91.
68. Hirø SK, Bhat GJ, Patel JB et al. Early congenital syphilis: clinico-radiological features in 202 patients. Sex Transm Dis 1985; 12: 177-83.
69. Freiman I, Super M. Thrombocytopenia and congenital syphilis in South African Bantu infants. Arch Dis Child 1966; 41: 87-90.
70. Dunlop EMC, Zwink RB. Incidence of corneal changes in congenital syphilis. Br J Vener Dis 1954; 30: 201-9.
71. Robinson RCV. Congenital syphilis. Arch Dermatol 1969; 99: 599-610.
72. Britten MJA, Palmer CAL. Glaucoma and inactive syphilitic interstitial keratitis. Br J Ophthalmol 1964; 48: 181-90.
73. Horne GO. Topical cortisone in syphilitic interstitial keratitis. Br J Vener Dis 1955; 31: 9-24.
74. Borella L, Goobar JE, Clark GM. Synovitis of the knee joints in late congenital syphilis. JAMA 1962; 180: 190-2.
75. Morrison AW. Management of severe deafness in adults. Proc R Soc Med 1969; 62: 959-67.
76. Bonugli FS. Involvement of aortic valve and ascending aorta in congenital syphilis. Br J Vener Dis 1961; 37: 257-67.
77. Larsen SA, Steiner BM, Rudolph AH. Laboratory diagnosis and interpretation of tests for syphilis. Clin Microbiol Rev 1995; 8: 1-21.
78. Kouznetsov AV, Prinz JC. Molecular diagnosis of syphilis: the Schaudinn-Hofmann lymph-node biopsy. Lancet 2002; 360: 388-9.
79. Nelson RA, Mayer MM. Immobilization of Treponema pallidum in vitro by antibody produced in syphilitic infection. J Exp Med 1949; 89: 369-93.
80. Laurell AB, Hederstedt B. Fractionation of TPI antibodies and Wassermann reagins. Acta Pathol Microbiol Scand 1958; 44: 88-91.
81. Wilkinson AE. Studies on the treponemal immobilization test. Br J Vener Dis 1954; 30: 144-55.
82. Deacon WE, Falcone VH, Harris AD. A fluorescent test for treponemal antibodies. Proc Soc Exp Biol Med 1957; 96: 477-80.
83. Nielsen HA, Idsøe O. Evaluation of the fluorescent treponemal antibody test (FTA). Acta Pathol Microbiol Scand 1963; 57: 331-47.
84. Deacon WE, Lucas JB, Price EV. Fluorescent treponemal antibody absorption (FTA/ABS) test for syphilis. JAMA 1966; 198: 624-8.
85. Rathlev T. Haemagglutination test utilizing pathogenic Treponema pallidum for the sero-diagnosis of syphilis. Br J Vener Dis 1967; 43: 181-5.
86. Sequiera PJL, Eldridge AE. Treponema haemagglutination test. Br J Vener Dis 1973; 49: 242-8.
87. O'Neil P, Warner RW, Nicol CS. Treponema pallidum haemagglutination assay in the routine serodiagnosis of treponemal disease. Br J Vener Dis 1973; 49: 427-31.
88. Robertson DHH, McMillan A, Young H et al. Clinical value of the Treponema pallidum haemagglutination test. Br J Vener Dis 1975; 51: 79-82.
89. Eggelston SI, Turner AJL, for the PHLS Syphilis Serology Working Group. Serological testing for syphilis. Commun Dis Public Health 2000; 3: 158-62.
90. Byrne RE, Laska S, Bell M et al. Evaluation of a Treponema pallidum Western immunoblot assay as a confirmatory test for syphilis. J Clin Microbiol 1992; 30: 115-22.
91. Herring AJ, Ballard RC, Pope V et al. A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived sera. Sex Transm Infect 2006; 82: v7-12.
92. Forster WD, Kerchan LLO. Biologically false positive Wassermann reactions in Uganda. Br J Vener Dis 1966; 42: 272-5.
93. Garner MR, Backhouse JL, Collins CA et al. Serological tests for treponemal infection in leprosy patients. Br J Vener Dis 1969; 45: 19-22.
94. British Co-operative Clinical Group. An examination of the treponemal immobilization test in the investigation of positive serological tests for syphilis in pregnancy. Br J Vener Dis 1959; 35: 162-8.
95. Catterall RD. Collagen disease and the chronic biological false positive phenomenon. QJM 1961; 30: 41-55.
96. Moore JE, Mohr CF. Biologically false positive serologic tests for syphilis. JAMA 1951; 150: 467-73.
97. Gibowski M, Neumann E. Non-specific test results to syphilis in dermatological diseases. Br J Vener Dis 1980; 56: 17-9.
98. Kraus SJ, Haserick JR, Lantz MA. Atypical FTA-ABS test fluorescence in lupus erythematous patients. JAMA 1970; 211: 2140-1.
99. McKenna CH, Schroeter AL, Kierland RR et al. The fluorescent treponemal antibody absorbed (FTA-ABS) test beading phenomenon in connective tissue diseases. Mayo Clin Proc 1973; 48: 545-8.
100. Shore RN, Faricelli JA. Borderline and reactive FTA-ABS results in lupus erythematous. Arch Dermatol 1977; 113: 37-41.
101. Hunter EF, Russel S, Farshy CE et al. Evaluation of sera from patients with Lyme disease by FTA/ABS test for syphilis. Sex Transm Dis 1986; 13: 232-6.
102. Chang SN, Chung KY, Lee MG, Lee JB. Seroreversion of the serological tests for syphilis in the newborns born to treated syphilitic mothers. Genitourin Med 1995; 71: 68-70.
103. Clinical Effectiveness Group. National Guideline for the Management of Early Syphilis. Association of Genitourinary Medicine (AGUM) and Medical Society for the Study of Venereal Diseases (MSSVD). www.mssvd.org.uk/PDF/CEG2001/early$Final0502.pdf
104. Clinical Effectiveness Group. National Guideline for the Management of Late Syphilis. Association of Genitourinary Medicine (AGUM) and Medical Society for the Study of Venereal Diseases (MSSVD). www.mssvd.org.uk/PDF/CEG2001/late$Final0502.pdf
105. Goh BT, van der Voorst Vader PC. European guideline for the management of syphilis. Intern J STD AIDS 2001; 12 (Suppl. 3): 14-26.
106. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. MMWR 2006; 55 (RR11): 1-94.
107. Hook EW 3rd, Martin DH, Stephens J et al. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2002; 29: 486-90.
108. Smith NH, Musher DM, Huang DB et al. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int J STD AIDS 2004; 15: 328-32.
109. Riedner G, Rusizoka M, Todd J et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 2005; 353: 1236-44.
110. Ronald AR, Silverman M, McCutchan JA et al. Evaluation of new anti-infective drugs for the treatment of syphilis. Clin Infect Dis 1992; 15 (Suppl. 1): 140-7.
111. Gordon SM, Eaton ME, George R et al. The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodefi-ciency virus infection. N Engl J Med 1994; 331: 1469-73.
112. Malone JL, Wallace MR, Hendrick BB et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med 1995; 99: 55-63.
113. Paryani SG, Vaughn AJ, Crosby M, Lawrence S. Treatment of asymptomatic congenital syphilis: benzathine versus procaine penicillin G therapy. J Pediatr 1994; 125: 471-5.
114. Hook EW III, Stephens J, Ennis DM. Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis. Ann Intern Med 1999; 313: 434-7.
115. Engelgau MM, Woernie CH, Rolfs RT et al. Control of epidemic syphilis: the results of an intervention campaign using social networks. Sex Transm Dis 1995; 22: 203-9.
116. Kohl KS, Farley TA, Ewell J, Scioneaux J. Usefulness of partner notification for syphilis control. Sex Transm Dis 1999; 26: 201-7.
117. WHO. Treponemal Infections. Technical Reports Series 674. Geneva: World Health Organization, 1982.
118. WHO. Control of Sexually Transmitted Diseases. Geneva: World Health Organization, 1985.
119. WHO. Expert Committee on Venereal Diseases and Treponematoses. Sixth Report. Technical Report Series, No. 736. Geneva: World Health Organization, 1986.
120. Terris-Prestholt F, Watson-Jones D, Mugeye K et al. Is antenatal syphilis screening still cost effective in sub-Saharan Africa? Sex Transm Infect 2003; 79: 375-81.
121. Blandford JM, Gift TL, Vasaikar S et al. Cost-effectiveness of on-site antenatal screening to prevent congenital syphilis in rural eastern Cape Province, Republic of South Africa. Sex Transm Dis 2007; 34 (Suppl. 7): S61-6.
122. Qulohle DC, Hoosen AA, Moodley J et al. Serological screening for sexually transmitted diseases in pregnancy: is there any value in re-screening for HIV and syphilis at the time of delivery? Genitourin Med 1995; 71: 65-7.
123. Lutwick LI. Gonococcal infections. E-medicine, 2007. http://www.emedicine.com/med/topic922.htm.
124. WHO. Global Strategy for the Prevention and Control of Sexually Transmitted Infections: 2006-2015. Key messages. Geneva: WHO, 2006.
125. Fenton KA, Lowndes CM. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm Infect 2004; 80: 255-63.
126. Aral SO, Fenton KA, Holmes KK. Sexually transmitted diseases in the USA: temporal trends. Sex Transm Infect 2007; 83: 257-66.
127. Peter NG, Clark LR, Jaeger JR. Fitz-Hugh-Curtis syndrome: a diagnosis to consider in women with right upper quadrant pain. Cleve Clin J Med 2004; 71: 233-9.
128. Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am 2005; 19: 853-61.
129. Cook RL, Hutchison SL, Østergaard L et al. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005; 142: 914-25.
130. Chernesky MA, Jang DE. APTIMA transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Rev Mol Diagn 2006; 6: 519-25.
131. Whiley DM, Tapsall JW, Sloots TP. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J Mol Diagn 2006; 8: 3-15.
132. Choudhury B, Risley CL, Ghani AC et al. Identification of individuals with gonorrhoea within sexual networks: a population-based study. Lancet 2006; 368: 139-46.
133. Bilek N, Martin IM, Bell G et al. Concordance between Neisseria gonorrhoeae genotypes recovered from known sexual contacts. J Clin Microbiol 2007; 45: 3564-7.
134. Martin IMC, Hoffmann S, Ison CA. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother 2006; 58: 587-93.
135. CDC, Worokowski KA, Berman SM. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2006; 55 (RR-11): 1-94.
136. CDC. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep 2007; 56: 332-6.
137. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhoea in adults in the United States. Clin Infect Dis 2007; 44 (Suppl. 3): S84-101.
138. Clinical Effectiveness Group, BASHH. National Guideline on the Diagnosis and Treatment of Gonorrhoea in Adults 2005. www.bashh.org/guidelines/2005/gc_final_0805.pdf.
139. Hogan RJ, Mathews SA, Mukhopadhyay S et al. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 2004; 72: 1843-55.
140. Low N, McCarthy A, Macleod J et al. Chlamydia Screening Studies Project Group. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess 2007; 11: iii-iv, ix-xii, 1-165.
141. Simms I, Battison T, Macintosh M et al. The National Chlamydia Screening Programme and the NICE guidance on one-to-one interventions: remember the under-25s. Sex Transm Infect 2007; 83: 171.
142. Adams EJ, Turner KM, Edmunds WJ. The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect 2007; 83: 267-74.
143. Scott Lamontagne D, Baster K, Emmett L et al. Chlamydia Recall Study Advisory Grou. Incidence and reinfection rates of genital chlamydial infection among women aged 16-24 years attending general practice, family planning and genitourinary medicine clinics in England: a prospective cohort study by the Chlamydia Recall Study Advisory Group. Sex Transm Infect 2007; 83: 292-303.
144. Hamlyn E, Taylor C. Sexually transmitted proctitis. Postgrad Med J 2006; 82: 733-6.
145. Nozu T, Komiyama H. Fitz-Hugh-Curtis syndrome. Ann Intern Med 2006; 45: 221-2.
146. Chernesky MA, Jang DE. APTIMA transcription-mediated amplification assays for Chlamydia trachomatis and Neisseria gonorrhoeae. Expert Rev Mol Diagn 2006; 6: 519-25.
147. Hadgu A. Issues in Chlamydia trachomatis testing by nucleic acid amplification test. J Infect Dis 2006; 193: 1335-6.
148. Björkman J, Jonsson L, Nilsson P. Prevalence Of the new genetic variant of Chlamydia trachomatis in Södra Älvsborg County, Västra Götaland Region, Sweden. Eurosurveillance 2007; 6. http://www.eurosurveillance.org/ew/2007/070614.asp#4
149. Skidmore S, Horner P, Herring A et al. Chlamydia Screening Studies (ClaSS) Project Group. Vulvovaginal-swab or first-catch urine specimen to detect Chlamydia trachomatis in women in a community setting? J Clin Microbiol 2006; 44: 4389-94.
150. Hoebe CJ, Rademaker CW, Brouwers EE et al. Acceptability of self-taken vaginal swabs and first-catch urine samples for the diagnosis of urogenital Chlamydia trachomatis and Neisseria gonorrhoeae with an amplified DNA assay in young women attending a public health sexually transmitted disease clinic. Sex Transm Dis 2006; 33: 491-5.
151. Keane FE, Bendall R, Saulsbury N, Haddon L. A comparison of self-taken vulvovaginal and cervical samples for the diagnosis of Chlamydia trachomatis infection by polymerase chain reaction. Int J STD AIDS 2007; 18: 98-100.
152. Clinical Effectiveness Group 2006. UK National Guideline for the Management of Genital Tract Infection with Chlamydia trachomatis. www.bashh.org/guidelines/2006/chlamydia_0706.pdf
153. Peterman TA, Tian LH, Metcalf CA et al. RESPECT-2 Study Group. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006; 145: 564-72.
154. Richardson D, Goldmeier D. Lymphogranuloma venereum: an emerging cause of proctitis in men who have sex with men. Int J STD AIDS 2007; 18: 11-4.
155. Mabey D, Peeling RW. Lymphogranuloma venereum. Sex Transm Infect 2002; 78: 90-2.
156. Nieuwenhuis RF, Ossewaarde JM, Gotz HM et al. Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar L2 proctitis in The Netherlands among men who have sex with men. Clin Infect Dis 2004; 39: 996-1003.
157. Gotz HM, van Doornum G, Niesters HG et al. A cluster of acute hepatitis C virus infection among men who have sex with men-results from contact tracing and public health implications. AIDS 2005; 19: 969-74.
158. Ward H, Martin I, MacDonald N et al. Lymphogranuloma venereum in the United Kingdom. Clin Infect Dis 2007; 44: 26-32.
159. Hamill M, Benn P, Carder C et al. The clinical manifestations of lymphogranuloma venereum (LGV) versus non-LGV strains of Chlamydia trachomatis: a casecontrol study in homosexual men. Int J STD AIDS 2007; 18: 472-5.
160. Morre SA, Spaargaren J, Fennema JS et al. Real-time polymerase chain reaction to diagnose lymphogranuloma venereum. Emerg Infect Dis 2005; 11: 1311-2.
161. Pathella P, Blank S, Shillinger JA. Lymphogranuloma venereum: old pathogen, new story. Curr Infect Dis Rep 2007; 44: 143-50.
162. Sturm PD, Moodley P, Govender K et al. Molecular diagnosis of lymphogranuloma venereum in patients with genital ulcer disease. J Clin Microbiol 2005; 43: 2973-5.
163. Perine PL, Stamm WE. Lymphogranuloma venereum. In: Holmes KK, Sparling PF, Mardh PA et al., eds. Sexually Transmitted Diseases, 3rd edn. New York: McGraw Hill, 1999: 423-32.
164. British Association of Sexual Health and HIV. 2006 National Guideline for the Management of Lymphogranuloma Venereum (LGV). www.bashh.org/guidelines/2007/lgv_gdl_revised_final2_1106.pdf
165. Centres for Disease Control and Prevention. 2006 STD Treatment Guidelines. www.cdc.gov/std/treatment/
166. Lewis DA, Ison CA. Chancroid. Sex Transm Infect 2006; 82 (Suppl. 4): 19-20.
167. Bauer ME, Townsend CA, Ronald AR, Spinola SM. Localization of Haemophilus ducreyi in naturally acquired chancroidal ulcers. Microbes Infect 2006; 8: 2465-8.
168. Mackay IM, Harnett G, Jeoffreys N et al. Detection and discrimination of herpes simplex viruses, Haemophilus ducreyi, Treponema pallidum, and Calymmatobacterium (Klebsiella) granulomatis from genital ulcers. Clin Infect Dis 2006; 42: 1431-8.
169. Liu AY, Jiang MJ, Yin YP, Sun JF. Detection of pathogens causing genital ulcer disease by multiplex polymerase chain reaction. Chin Med Sci J 2005; 20: 273-5.
170. Ahmed HJ, Mbwana J, Gunnarsson E et al. Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two Tanzanian cities. Sex Transm Dis 2003; 30: 114-9.
171. Riedner G, Todd J, Rusizoka M et al. Possible reasons for an increase in the proportion of genital ulcers due to herpes simplex virus from a cohort of female bar workers in Tanzania. Sex Transm Infect 2007; 83: 91-6.
172. Nilsen A, Kasubi MJ, Mohn SC et al. Herpes simplex virus infection and genital ulcer disease among patients with sexually transmitted infections in Dar es Salaam, Tanzania. Acta Derm Venereol 2007; 87: 355-9.
173. Ussher JE, Wilson E, Campanella S et al. Haemophilus ducreyi causing chronic skin ulceration in children visiting Samoa. Clin Infect Dis 2007; 44: e85-7.
174. Janowicz DM, Tenner-Racz K, Racz P et al. Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication. J Infect Dis 2007; 195: 1443-51.
175. Annan NT, Lewis DA. Treatment of chancroid in resource-poor countries. Expert Rev Anti Infect Ther 2005; 3: 295-306.
176. Roy-Leon JE, Lauzon WD, Toye B et al. In vitro and in vivo activity of combination antimicrobial agents on Haemophilus ducreyi. J Antimicrob Chemother 2005; 56: 552-8.
177. Hoyo C, Hoffman I, Moser BK et al. Improving the accuracy of syndromic diagnosis of genital ulcer disease in Malawi. Sex Transm Dis 2005; 32: 231-7.
178. Weiss HA, Thomas SL, Munabi SK, Hayes RJ. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect 2006; 82: 101-10.
179. Donovan C. Ulcerating granuloma of the pudenda. Indian Medical Gazette 1905; 40: 414.
180. O'Farrell N. Donovanosis. Sex Transm Infect 2002; 78: 452-7.
181. Richens J. Donovanosis (granuloma inguinale). Sex Transm Infect 2006; 82 (Suppl. IV): iv21-iv22.
182. Carter JS, Bowden FJ, Bastian I et al. Phylogenetic evidence for reclassification of Calymmatobacterium granulomatis as Klebsiella granulomatis comb nov. Int J Systematic Bacteriol 1999; 49: 1695-700.
183. Kharsany AB, Hoosen AA, Kiepiela P et al. Phylogenetic analysis of Calymmatobacterium granulomatis based on 16S rRNA gene sequences. J Med Microbiol 1999; 48: 841-7.
184. Hart G. Donovanosis (granuloma inguinale). Clin Infect Dis 1997; 25: 24-32.
185. Cannefax GR. The technique of the tissue spread method for demonstrating Donovan bodies. J Vener Dis Inform 1948; 29: 210-4.
186. Sehgal VN, Jain MK. Tissue section Donovan bodies-identification through slow Giemsa (overnight) technique. Dermatologica 1987; 174: 228-31.
187. O'Farrell N, Hoosen AA, Coetzee K et al. A rapid stain for the diagnosis of granuloma inguinale. Genitourin Med 1990; 66: 200-1.
188. Kharsany AB, Hoosen AA, Kiepiela P et al. Growth and cultural characteristics of Calymmatobacterium granulomatis-the aetiological agent of granuloma inguinale (donovanosis). J Med Microbiol 1997; 46: 579-85.
189. Carter J, Hutton S, Sriprakash KS et al. Culture of the causative organism of donovanosis (Calymmatobacterium granulomatis) in HEp-2 cells. J Clin Microbiol 1997; 35: 2915-7.
190. Carter J, Bowden FJ, Sriprakash KS et al. Diagnostic polymerase chain reaction for donovanosis. Clin Infect Dis 1999; 28: 1168-9.
191. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR 2006; 55 (RR11): 1-94.